EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nationwide Pilot Newborn Screening for Spinal Muscular Atrophy and Inborn Errors of Immunity in Greece

Iro Skopa, Eleftheria Dikoglou-Tzanetatou, Theoni Petropoulou, Elisavet Kouvidi, Marianna Tzanoudaki, Maria Grigoriadou, Eleni Leiletzoglou, Myrto Poulou, Roser Pons, Dimitrios Zafeiriou, Christina Kanaka Gantenbein, Aggeliki Kolialexi

International Journal of Neonatal Screening · 12.11.2026 · 12 (4) · 99

DOI: 10.3390/ijns12040099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 12.11.2026. Verfasst von Iro Skopa und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Greek Recovery and Resilience Fund.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Newborn screening for inborn errors of immunity and spinal muscular atrophy (SMA) enables early identification of infants at risk for severe disorders, facilitating timely treatment and improved outcomes. This study describes the first Greek experience with combined screening for SMA and severe T- and B-cell lymphopenias using SMN1 exon 7 analysis and T-cell receptor excision circles (TREC)/kappa-deleting recombination excision circles (KREC) measurements, using a single dried blood spot (DBS) sample. In 2026, 29,460 newborns were screened using a commercially available in vitro diagnostic kit. TREC and KREC were assessed semi-quantitatively, while SMA screening was based on qualitative detection of the SMN1 exon 7 target. Of these, 2168 (7.36%) required duplicate retesting, with 481 requiring a second DBS sample. Among the 481 newborns for whom a second DBS card was requested, 469 cards were received. Of these, 446 were classified as negative, 13 remained inconclusive, 4 were referred for genetic/immunological confirmatory evaluation, 2 remained under immunological follow-up, and 4 demonstrated recovery on repeat testing. Confirmatory evaluation identified four clinically significant cases: two with SMA, one with severe T-cell lymphopenia associated with 22q11.2 deletion syndrome, and one with CHARGE syndrome. Several low TREC/KREC results normalized on repeat testing. This experience demonstrates the feasibility of combined screening and highlights the importance of appropriate follow-up and confirmatory evaluation.

Förderung

  • Greek Recovery and Resilience Fund

Zitieren

APA

Skopa, I., Dikoglou-Tzanetatou, E., Petropoulou, T., Kouvidi, E., Tzanoudaki, M., Grigoriadou, M., Leiletzoglou, E., Poulou, M., Pons, R., Zafeiriou, D., Gantenbein, C. K., & Kolialexi, A. (2026). Nationwide Pilot Newborn Screening for Spinal Muscular Atrophy and Inborn Errors of Immunity in Greece. International Journal of Neonatal Screening, 12(4), 99. https://doi.org/10.3390/ijns12040099

Vancouver

Skopa I, Dikoglou-Tzanetatou E, Petropoulou T, Kouvidi E, Tzanoudaki M, Grigoriadou M, et al. Nationwide Pilot Newborn Screening for Spinal Muscular Atrophy and Inborn Errors of Immunity in Greece. International Journal of Neonatal Screening. 2026;12(4):99. doi:10.3390/ijns12040099

BibTeX
@article{Skopa2026,
  author = {Skopa, Iro and Dikoglou-Tzanetatou, Eleftheria and Petropoulou, Theoni and Kouvidi, Elisavet and Tzanoudaki, Marianna and Grigoriadou, Maria and Leiletzoglou, Eleni and Poulou, Myrto and Pons, Roser and Zafeiriou, Dimitrios and Gantenbein, Christina Kanaka and Kolialexi, Aggeliki},
  title = {Nationwide Pilot Newborn Screening for Spinal Muscular Atrophy and Inborn Errors of Immunity in Greece},
  journal = {International Journal of Neonatal Screening},
  year = {2026},
  volume = {12},
  number = {4},
  pages = {99},
  doi = {10.3390/ijns12040099}
}
Kostenlos starten →